11-119372712-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_004205.5(USP2):c.769G>A(p.Gly257Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000257 in 1,518,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_004205.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP2 | NM_004205.5 | c.769G>A | p.Gly257Ser | missense_variant | 2/13 | ENST00000260187.7 | NP_004196.4 | |
USP2 | XM_005271721.6 | c.769G>A | p.Gly257Ser | missense_variant | 2/13 | XP_005271778.1 | ||
USP2 | XM_005271722.3 | c.769G>A | p.Gly257Ser | missense_variant | 2/13 | XP_005271779.1 | ||
USP2 | NM_001243759.2 | c.45+8761G>A | intron_variant | NP_001230688.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP2 | ENST00000260187.7 | c.769G>A | p.Gly257Ser | missense_variant | 2/13 | 1 | NM_004205.5 | ENSP00000260187.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000287 AC: 5AN: 174292Hom.: 0 AF XY: 0.0000435 AC XY: 4AN XY: 91974
GnomAD4 exome AF: 0.0000241 AC: 33AN: 1366562Hom.: 0 Cov.: 30 AF XY: 0.0000254 AC XY: 17AN XY: 670446
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74492
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at